BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20071423)

  • 1. Interactions at human ether-à-go-go-related gene channels.
    Friemel A; Zünkler BJ
    Toxicol Sci; 2010 Apr; 114(2):346-55. PubMed ID: 20071423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altering extracellular potassium concentration does not modulate drug block of human ether-a-go-go-related gene (hERG) channels.
    Limberis JT; Su Z; Cox BF; Gintant GA; Martin RL
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1059-65. PubMed ID: 17042915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.
    Rampe D; Roy ML; Dennis A; Brown AM
    FEBS Lett; 1997 Nov; 417(1):28-32. PubMed ID: 9395068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular determinants of hERG channel block by terfenadine and cisapride.
    Kamiya K; Niwa R; Morishima M; Honjo H; Sanguinetti MC
    J Pharmacol Sci; 2008 Nov; 108(3):301-7. PubMed ID: 18987434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel.
    Davie C; Pierre-Valentin J; Pollard C; Standen N; Mitcheson J; Alexander P; Thong B
    J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1302-9. PubMed ID: 15574182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular Binding of Terfenadine Competes with Its Access to Pancreatic ß-cell ATP-Sensitive K
    Zünkler BJ; Wos-Maganga M; Bohnet S; Kleinau A; Manns D; Chatterjee S
    J Membr Biol; 2023 Feb; 256(1):63-77. PubMed ID: 35763054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o.
    Diaz GJ; Daniell K; Leitza ST; Martin RL; Su Z; McDermott JS; Cox BF; Gintant GA
    J Pharmacol Toxicol Methods; 2004; 50(3):187-99. PubMed ID: 15519905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of HERG and Kv1.5 by ketoconazole.
    Dumaine R; Roy ML; Brown AM
    J Pharmacol Exp Ther; 1998 Aug; 286(2):727-35. PubMed ID: 9694927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acidification alters antiarrhythmic drug blockade of the ether-a-go-go-related Gene (HERG) Channels.
    Dong DL; Li Z; Wang HZ; Du ZM; Song WH; Yang BF
    Basic Clin Pharmacol Toxicol; 2004 May; 94(5):209-12. PubMed ID: 15125690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological inhibition of the hERG potassium channel is modulated by extracellular but not intracellular acidosis.
    DU CY; El Harchi A; Zhang YH; Orchard CH; Hancox JC
    J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1163-70. PubMed ID: 21489024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does terfenadine-induced ventricular tachycardia/fibrillation directly relate to its QT prolongation and Torsades de Pointes?
    Lu HR; Hermans AN; Gallacher DJ
    Br J Pharmacol; 2012 Jun; 166(4):1490-502. PubMed ID: 22300168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antihistamine fexofenadine does not affect I(Kr) currents in a case report of drug-induced cardiac arrhythmia.
    Scherer CR; Lerche C; Decher N; Dennis AT; Maier P; Ficker E; Busch AE; Wollnik B; Steinmeyer K
    Br J Pharmacol; 2002 Nov; 137(6):892-900. PubMed ID: 12411421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High affinity open channel block by dofetilide of HERG expressed in a human cell line.
    Snyders DJ; Chaudhary A
    Mol Pharmacol; 1996 Jun; 49(6):949-55. PubMed ID: 8649354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F463L increases the potential of dofetilide on human ether-a-go-go-related gene (hERG) channels.
    Cheng G; Wu J; Han W; Sun C
    Microsc Res Tech; 2018 Jun; 81(6):663-668. PubMed ID: 29573040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation gating determines drug potency: a common mechanism for drug blockade of HERG channels.
    Yang BF; Xu DH; Xu CQ; Li Z; Du ZM; Wang HZ; Dong DL
    Acta Pharmacol Sin; 2004 May; 25(5):554-60. PubMed ID: 15132818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating dynamic protocol-dependence of hERG potassium channel inhibition at 37 degrees C: Cisapride versus dofetilide.
    Milnes JT; Witchel HJ; Leaney JL; Leishman DJ; Hancox JC
    J Pharmacol Toxicol Methods; 2010; 61(2):178-91. PubMed ID: 20172036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of block of the hERG K+ channel by the scorpion toxin CnErg1.
    Hill AP; Sunde M; Campbell TJ; Vandenberg JI
    Biophys J; 2007 Jun; 92(11):3915-29. PubMed ID: 17369411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive effects of combined application of multiple hERG blockers.
    Margulis M; Sorota S
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):549-52. PubMed ID: 18475200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Possible Proarrhythmic Potency: Comparison of the Effect of Dofetilide, Cisapride, Sotalol, Terfenadine, and Verapamil on hERG and Native IKr Currents and on Cardiac Action Potential.
    Orvos P; Kohajda Z; Szlovák J; Gazdag P; Árpádffy-Lovas T; Tóth D; Geramipour A; Tálosi L; Jost N; Varró A; Virág L
    Toxicol Sci; 2019 Apr; 168(2):365-380. PubMed ID: 30561737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of metoclopramide and domperidone on HERG channels.
    Claassen S; Zünkler BJ
    Pharmacology; 2005 Apr; 74(1):31-6. PubMed ID: 15640612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.